Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma. | J Clin Med | 2023 | 36835825 | PubTator, text mining | PubMed |
| Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. | Genes (Basel) | 2023 | 36833320 | PubTator, text mining | PubMed |
| MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. | Cancers (Basel) | 2023 | 36831632 | PubTator, text mining | PubMed |
| A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. | Cancers (Basel) | 2023 | 36831529 | PubTator, text mining | PubMed |
| Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma. | Biomolecules | 2023 | 36830767 | PubTator, text mining | PubMed |
| miRinGO: Prediction of Biological Processes Indirectly Targeted by Human microRNAs. | Noncoding RNA | 2023 | 36827544 | PubTator, text mining | PubMed |
| Scaling-up strategies for controllable biosynthetic ZnO NPs using cell free-extract of endophytic Streptomyces albus: characterization, statistical optimization, and biomedical activities evaluation. | Sci Rep | 2023 | 36823304 | PubTator, text mining | PubMed |
| Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis. | Ann Transl Med | 2023 | 36819577 | PubTator, text mining | PubMed |
| Sex Significantly Impacts the Function of Major Depression-Linked Variants In Vivo. | Biol Psychiatry | 2023 | 36803612 | PubTator, text mining | PubMed |
| Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling. | Hepatology | 2023 | 36800849 | PubTator, text mining | PubMed |
| Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. | Front Immunol | 2023 | 36793710 | PubTator, text mining | PubMed |
| Conditioned Medium - Is it an Undervalued Lab Waste with the Potential for Osteoarthritis Management? | Stem Cell Rev Rep | 2023 | 36790694 | PubTator, text mining | PubMed |
| Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. | Nat Commun | 2023 | 36788224 | PubTator, text mining | PubMed |
| Exosomes for angiogenesis induction in ischemic disorders. | J Cell Mol Med | 2023 | 36786037 | PubTator, text mining | PubMed |
| Inhibition of specific signaling pathways rather than epigenetic silencing of effector genes is the leading mechanism of innate tolerance. | Front Immunol | 2023 | 36776861 | PubTator, text mining | PubMed |
| The Tumorigenic Role of Circular RNA-MicroRNA Axis in Cancer. | Int J Mol Sci | 2023 | 36769372 | PubTator, text mining | PubMed |
| The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36769116 | PubTator, text mining | PubMed |
| Therapeutic Potential of Bioactive Components from Scutellaria baicalensis Georgi in Inflammatory Bowel Disease and Colorectal Cancer: A Review. | Int J Mol Sci | 2023 | 36768278 | PubTator, text mining | PubMed |
| C/EBPβ Coupled with E2F2 Promoted the Proliferation of hESC-Derived Hepatocytes through Direct Binding to the Promoter Regions of Cell-Cycle-Related Genes. | Cells | 2023 | 36766839 | PubTator, text mining | PubMed |
| Extracellular vesicle RNA signaling in the liver tumor microenvironment. | Cancer Lett | 2023 | 36758739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=17